[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg].

Objective: To evaluate the efficacy and safety of a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide (HCTZ) 12.5 mg (TH) to telmisartan 80 mg (T) in Chinese patients who failed to respond adequately to treatment with T.

Method: This is a multi-center, randomized, double-blind, double-dummy clinical study.

[Retrospective analysis of drug treatment on inpatients with chronic heart failure].

Objective: To investigate drug treatment of inpatients with chronic heart failure(CHF) during the past 30 years in some areas and to provide more information on the treatment strategy of CHF.

Methods: In two centers a retrospective study was conducted. All data were taken from the hospitalized cases with chronic heart failure.

[Comparable analysis of in-hospital mortality in patients with acute myocardial infarction].

Objective: To investigate the change of the mortality of AMI and influence factors within 20 years.

Methods: Clinic data of 134 AMI patients from 1980 to 1983, 354 AMI patients from 1990 to 1993 and 817 AMI patients from 2000 to 2003 were comparably analyzed.

Results: In hospital mortality of AMI was 22.

[Analysis of factors correlated to death and reinfarction in patients with acute myocardial infarction].

Objective: To identify the predictors of death and reinfarction in patients with acute myocardial infarction (AMI) treated with urokinase (UK) thrombolysis or percutaneous transluminal coronary angioplasty (PTCA).

Methods: In ambispective cohort study, 97 cases of AMI were treated with UK thrombolytic therapy, while 93 cases of AMI were treated with PTCA. The patients' data about clinical outcome during hospital and follow-up periods were collected.